Impact of the Everolimus-eluting Bioresorbable Scaffold in Coronary Atherosclerosis.
Campos CM, Garcia-Garcia HM, Muramatsu T, de Araujo Gonçalves P, Onuma Y, Dudek D, Thuesen L, Webster MW, Kitslaar P, Veldhof S, Reiber JH, Nieman K, Ormiston JA, Serruys PW.
Campos CM, et al. Among authors: webster mw.
Rev Esp Cardiol (Engl Ed). 2016 Feb;69(2):109-16. doi: 10.1016/j.rec.2015.07.027. Epub 2015 Dec 28.
Rev Esp Cardiol (Engl Ed). 2016.
PMID: 26739828
Clinical Trial.